| Medical and Health Sciences | 2021-2025 | 372 | US 130 | 99.92 |
| Pathology and Forensic Medicine | Lifetime | 49 | US 27 | 99.79 |
| Pulmonary and Respiratory Medicine | Lifetime | 535 | US 285 | 99.25 |
| Rheumatology | Lifetime | 219 | US 93 | 99.12 |
| Dermatology | Lifetime | 494 | US 204 | 96.21 |
| Nephrology | Lifetime | 412 | US 195 | 96.21 |
| Pathology and Forensic Medicine | 2021-2025 | 3 | US 2 | 99.82 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 271 | US 84 | 97.63 |
| Dermatology | 2021-2025 | 192 | US 62 | 92.82 |
| Systemic Sclerosis and Related Diseases | Lifetime | 6 | US 2 | 99.80 |
| Dermatologic Treatments and Research | Lifetime | 7 | US 6 | 99.76 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 5 | US 3 | 99.72 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 21 | US 11 | 99.78 |
| Mast cells and histamine | Lifetime | 22 | US 12 | 99.44 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 15 | US 9 | 99.17 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 166 | US 83 | 99.01 |
| Eosinophilic Disorders and Syndromes | Lifetime | 136 | US 72 | 98.73 |
| Autoimmune Bullous Skin Diseases | Lifetime | 137 | US 50 | 98.68 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 232 | US 69 | 99.02 |
| Urticaria and Related Conditions | Lifetime | 143 | US 55 | 98.52 |
| Case Reports on Hematomas | Lifetime | 28 | US 11 | 98.17 |
| Systemic Lupus Erythematosus Research | Lifetime | 710 | US 240 | 97.96 |
| Connective Tissue Growth Factor Research | Lifetime | 46 | US 18 | 97.08 |
| Eosinophilic Esophagitis | Lifetime | 679 | US 244 | 96.88 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 287 | US 100 | 96.26 |
| Spondyloarthritis Studies and Treatments | Lifetime | 312 | US 63 | 96.89 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 672 | US 187 | 96.04 |
| Skin Diseases and Diabetes | Lifetime | 162 | US 72 | 95.35 |
| Celiac Disease Research and Management | Lifetime | 914 | US 196 | 90.90 |
| Dupuytren's Contracture and Treatments | Lifetime | 584 | US 210 | 75.45 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 203 | US 59 | 64.94 |
| Dermatologic Treatments and Research | 2021-2025 | 1 | US 1 | 99.67 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 1 | US 1 | 99.84 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 1 | US 1 | 99.84 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 7 | US 5 | 99.75 |
| Mast cells and histamine | 2021-2025 | 8 | US 4 | 99.11 |
| Skin Diseases and Diabetes | 2021-2025 | 12 | US 7 | 93.23 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 157 | US 35 | 94.54 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 471 | US 169 | 82.85 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 491 | US 162 | 76.91 |
| Genital Health and Disease | 2021-2025 | 786 | US 239 | 73.40 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 888 | US 312 | 74.27 |
| Skin and Cellular Biology Research | 2021-2025 | 416 | US 91 | 67.99 |
| Dermatological and Skeletal Disorders | 2021-2025 | 421 | US 113 | 59.21 |
| Connective Tissue Growth Factor Research | 2021-2025 | 119 | US 16 | 57.94 |
